Instead of developing a new drug from the ground up — a time-consuming and costly process — experts say that repurposing medications could accelerate…
For retired neurologist Daniel Gibbs, an Alzheimer’s diagnosis gave him not only a sense of relief, but a new lifestyle: one of healthier living,…
Retired neurologist Daniel Gibbs speaks about his own Alzheimer’s diagnosis, his unusual and severe case of side effects in aducanumab (Aduhelm) clinical trials, and…
In light of last week’s long-awaited FDA decision on experimental Alzheimer’s treatment aducanumab, a panel of clinical trials experts looks at why Alzheimer’s drug…
The FDA’s approval of Biogen’s new anti-amyloid drug Aduhelm was a landmark moment for Alzheimer’s — and it comes with no small amount of…
Cinical trial investigators for aducanumab (Aduhelm) discuss the significance of the drug’s recent FDA approval, the controversy surrounding its efficacy, and the uncertainty ahead….
Image: Phil Gutis receives an aducanumab infusion while carrying out his “silly shoe challenge.” Phil Gutis reflects on the significance of participating in the…
Nearly every Alzheimer’s clinical trial has been deemed a failure, yet some participants have positively responded to experimental treatment. Now, scientists are developing predictive…
As part of our LiveTalk series, Being Patient spoke with Dr. Jason Karlawish about the early diagnosis of Alzheimer’s and why it’s important for…
Expressive arts like music, painting, and even dance have the potential to evoke powerful emotion and long-buried memories in people living with Alzheimer’s. For…
After the deaths of close family members and giving birth to her child, Kara Kirby began experiencing changes in her behavior and personality. Clinicians…
Biogen’s aducanumab — a human antibody-based drug that targets beta-amyloid plaques, which are found in the brains of people with Alzheimer’s — has gone…
There is growing recognition that repetitive head impacts increases the risk of CTE, a brain disease that can only be definitely diagnosed at autopsy….
Scientists are diversifying their approaches to finding an effective treatment for Alzheimer’s as clinical trials targeting beta-amyloid plaques, one of the hallmarks of the…
In search of an animal model more comparable to the human brain, Alzheimer’s researchers are turning from mice to monkeys. Animal testing remains controversial,…